Skip to main content

James C. Robinson receives research grant to analyze price markups of infused drugs

  • Published

The National Institute for Health Care Management (NIHCM) Foundation has awarded James C. Robinson, a Berkeley Public Health professor of health economics, a $50,000 research grant for 2024.

Robinson, who is the Leonard D. Schaeffer Endowed Chair, Health Economics and Policy and director of the Berkeley Center for Health Technology, will use the funding to continue his analyses of prices and utilization for complex infused drugs and biologics used to treat cancer, auto-immune disease and other complex conditions.

“Deeper insight into the economics of these innovative medications is essential to help the nation better balance the competing needs for affordability and access, on the one hand, and R&D investment and innovation, on the other,” Robinson said.

Robinson was lead author of a study published in The New England Journal of Medicine on January 25, 2024, which found that a large share of insurer payments for drugs, which are intended to support further research and development, are instead siphoned off by hospitals for their own use.

His new study will quantify 2020–23 trends in price markups and profit margins earned by hospitals and physician practices from 80 infused drugs, biologics and biosimilars. The study will cover 600,000 patients and 6 million infusion visits over the four-year period.

People of UCBPH found in this article include:

James C. Robinson receives research grant to analyze price markups of infused drugs © 2024 by UC Berkeley School of Public Health is licensed under CC BY-NC-ND 4.0 Creative Commons Credit must be given to the creator Only noncommercial use is permitted No derivatives or adaptations are permitted
  • What is CC BY-NC-ND 4.0?

    CC BY-NC-ND 4.0

    Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

    You are free to:
    • Share — copy and redistribute the material in any medium or format
    • The licensor cannot revoke these freedoms as long as you follow the license terms.
    Under the following terms:
    • BY Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
    • NC NonCommercial — You may not use the material for commercial purposes.
    • ND NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
    • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
    Learn more:

More in category “Newsroom”:

How is the federal funding landscape affecting rural health?

His new study will quantify trends in price markups and profit margins earned by hospitals and physician practices from drugs, biologics and biosimilars.
October 29, 2025

Dean Michael C. Lu elected to the National Academy of Medicine

Health Policy and Management expert Kimberly MacPherson on threats to healthcare in rural America, where about 20% of the nation’s population lives.
October 20, 2025

Postdoctoral scholar Tulika Singh named 2025 STAT Wunderkind

Lu’s contributions to medicine have been recognized with one of the field’s highest honors.
October 16, 2025

What’s going on with the COVID-19 vaccine now?

STAT—a publication covering health, life science, medicine, and biotech news—calls out Singh’s work on increasing immune system effectiveness.
October 14, 2025
View all in category “Newsroom”
©2025 UC Regents; all rights reserved